Oral and sublingual immunotherapy for food allergy: Current progress and future directions

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 781-787

  Moran, Timothy P ^a   Vickery, Brian P ^b   Burks, A Wesley ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ALLERGEN; OMALIZUMAB;

ACCIDENT; DESENSITIZATION; EPIDEMIC; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; PREVALENCE; QUALITY OF LIFE; REVIEW; THERAPY EFFECT; WESTERN HEMISPHERE;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; CLINICAL TRIALS AS TOPIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

EID: 84889082591     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.07.011     Document Type: Review

References (48)

1. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A., Plaut M., Cooper S.F., Fenton M.J., Arshad S.H., et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010, 126:S1-S58.
2. Chafen J.J., Newberry S.J., Riedl M.A., Bravata D.M., Maglione M., Suttorp M.J., Sundaram V., Paige N.M., Towfigh A., Hulley B.J., et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010, 303:1848-1856.
3. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124:1549-1555.
4. Osborne N.J., Koplin J.J., Martin P.E., Gurrin L.C., Lowe A.J., Matheson M.C., Ponsonby A.L., Wake M., Tang M.L., Dharmage S.C., et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol 2011, 127. 668-676 e661-662.
5. Sicherer S.H., Munoz-Furlong A., Godbold J.H., Sampson H.A. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010, 125:1322-1326.
6. Burks A.W., Jones S.M., Wood R.A., Fleischer D.M., Sicherer S.H., Lindblad R.W., Stablein D., Henning A.K., Vickery B.P., Liu A.H., et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012, 367:233-243.
7. Vickery B.P., Scurlock A.M., Jones S.M., Burks A.W. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol 2011, 127:576-584. quiz 585-576.
8. Bedoret D., Singh A.K., Shaw V., Hoyte E.G., Hamilton R., DeKruyff R.H., Schneider L.C., Nadeau K.C., Umetsu D.T. Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol 2012, 5:267-276.
9. Skripak J.M., Nash S.D., Rowley H., Brereton N.H., Oh S., Hamilton R.G., Matsui E.C., Burks A.W., Wood R.A. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008, 122:1154-1160.
10. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., Shreffler W.G., Steele P., Henry K.A., Adair M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124. 292-300 300.e291-297.
11. Kim E.H., Bird J.A., Kulis M., Laubach S., Pons L., Shreffler W., Steele P., Kamilaris J., Vickery B., Burks A.W. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011, 127. 640-646 e641.
12. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., Hiegel A., Kamilaris J., Carlisle S., Yue X., et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011, 127:654-660.
13. Meglio P., Bartone E., Plantamura M., Arabito E., Giampietro P.G. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004, 59:980-987.
14. Buchanan A.D., Green T.D., Jones S.M., Scurlock A.M., Christie L., Althage K.A., Steele P.H., Pons L., Helm R.M., Lee L.A., et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007, 119:199-205.
15. Longo G., Barbi E., Berti I., Meneghetti R., Pittalis A., Ronfani L., Ventura A. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008, 121:343-347.
16. Keet C.A., Frischmeyer-Guerrerio P.A., Thyagarajan A., Schroeder J.T., Hamilton R.G., Boden S., Steele P., Driggers S., Burks A.W., Wood R.A. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012, 129. 448-455, 455 e441-445.
17. Fleischer D.M., Burks A.W., Vickery B.P., Scurlock A.M., Wood R.A., Jones S.M., Sicherer S.H., Liu A.H., Stablein D., Henning A.K., et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013, 131. 119-127 e111-117.
18. Enrique E., Pineda F., Malek T., Bartra J., Basagana M., Tella R., Castello J.V., Alonso R., de Mateo J.A., Cerda-Trias T., et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005, 116:1073-1079.
19. Fernandez-Rivas M., Garrido Fernandez S., Nadal J.A., Diaz de Durana M.D., Garcia B.E., Gonzalez-Mancebo E., Martin S., Barber D., Rico P., Tabar A.I. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009, 64:876-883.
20. Chin S.J., Vickery B.P., Kulis M.D., Kim E.H., Varshney P., Steele P., Kamilaris J., Hiegel A.M., Carlisle S.K., Smith P.B., et al. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol 2013, 132:476-478.
21. Sampson H.A., Gerth van Wijk R., Bindslev-Jensen C., Sicherer S., Teuber S.S., Burks A.W., Dubois A.E.J., Beyer K., Eigenmann P.A., Spergel J.M., et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy. Asthma & Immunology - European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol 2012, 130:1260-1274.
22. Nguyen-Luu N.U., Ben-Shoshan M., Alizadehfar R., Joseph L., Harada L., Allen M., St-Pierre Y., Clarke A. Inadvertent exposures in children with peanut allergy. Pediatr Allergy Immunol 2012, 23:133-139.
23. Sanchez-Garcia S., Rodriguez Del Rio P., Escudero C., Martinez-Gomez M.J., Ibanez M.D. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol 2012, 129:1155-1157.
24. Yeung J.P., Kloda L.A., McDevitt J., Ben-Shoshan M., Alizadehfar R. Oral immunotherapy for milk allergy. Cochrane Database Syst Rev 2012, 11:CD009542.
25. Nurmatov U., Venderbosch I., Devereux G., Simons F.E., Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012, 9:CD009014.
26. Sampson H.A. Peanut oral immunotherapy: is it ready for clinical practice?. J Allergy Clin Immun 2013, 1:15-21.
27. Cooke S.K., Sampson H.A. Allergenic properties of ovomucoid in man. J Immunol 1997, 159:2026-2032.
28. Nowak-Wegrzyn A., Bloom K.A., Sicherer S.H., Shreffler W.G., Noone S., Wanich N., Sampson H.A. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008, 122. 342-347, 347 e341-342.
29. Lemon-Mule H., Sampson H.A., Sicherer S.H., Shreffler W.G., Noone S., Nowak-Wegrzyn A. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008, 122. 977-983 e971.
30. Kim J.S., Nowak-Wegrzyn A., Sicherer S.H., Noone S., Moshier E.L., Sampson H.A. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011, 128. 125-131 e122.
31. Leonard S.A., Sampson H.A., Sicherer S.H., Noone S., Moshier E.L., Godbold J., Nowak-Wegrzyn A. Dietary baked egg accelerates resolution of egg allergy in children. J Allergy Clin Immunol 2012, 130. 473-480 e471.
32. Bannon G.A., Cockrell G., Connaughton C., West C.M., Helm R., Stanley J.S., King N., Rabjohn P., Sampson H.A., Burks A.W. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 2001, 124:70-72.
33. Li X.M., Srivastava K., Grishin A., Huang C.K., Schofield B., Burks W., Sampson H.A. Persistent protective effect of heat-killed Escherichia coli producing "engineered" recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003, 112:159-167.
34. Wood R.A., Sicherer S.H., Burks A.W., Grishin A., Henning A.K., Lindblad R., Stablein D., Sampson H.A. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy 2013, 68:803-808.
35. Leung D.Y., Sampson H.A., Yunginger J.W., Burks A.W., Schneider L.C., Wortel C.H., Davis F.M., Hyun J.D., Shanahan W.R. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003, 348:986-993.
36. Sampson H.A., Leung D.Y., Burks A.W., Lack G., Bahna S.L., Jones S.M., Wong D.A. A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 2011, 127. 1309-1310 e1301.
37. Nadeau K.C., Schneider L.C., Hoyte L., Borras I., Umetsu D.T. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011, 127:1622-1624.
38. Srivastava K.D., Kattan J.D., Zou Z.M., Li J.H., Zhang L., Wallenstein S., Goldfarb J., Sampson H.A., Li X.M. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005, 115:171-178.
39. Song Y., Qu C., Srivastava K., Yang N., Busse P., Zhao W., Li X.M. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. J Allergy Clin Immunol 2010, 126. 1208-1217 e1203.
40. Wang J., Patil S.P., Yang N., Ko J., Lee J., Noone S., Sampson H.A., Li X.M. Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol 2010, 105:75-84.
41. Patil S.P., Wang J., Song Y., Noone S., Yang N., Wallenstein S., Sampson H.A., Li X.M. Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: extended phase I study. J Allergy Clin Immunol 2011, 128. 1259-1265 e1252.
42. Beeh K.M., Kanniess F., Wagner F., Schilder C., Naudts I., Hammann-Haenni A., Willers J., Stocker H., Mueller P., Bachmann M.F., et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol 2013, 131:866-874.
43. Jouvin M.H., Kinet J.P. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis. J Allergy Clin Immunol 2012, 130:3-10.
44. Pelaia G., Vatrella A., Maselli R. The potential of biologics for the treatment of asthma. Nat Rev Drug Discov 2012, 11:958-972.
45. Dupont C., Kalach N., Soulaines P., Legoue-Morillon S., Piloquet H., Benhamou P.H. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010, 125:1165-1167.
46. De Souza Reboucas J., Esparza I., Ferrer M., Sanz M.L., Irache J.M., Gamazo C. Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. J Biomed Biotechnol 2012, 2012:474605.
47. Reboucas Jde S., Irache J.M., Camacho A.I., Esparza I., Del Pozo V., Sanz M.L., Ferrer M., Gamazo C. Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties. Eur J Pharm Biopharm 2012, 82:241-249.
48. Pajno G.B., Caminiti L., Ruggeri P., De Luca R., Vita D., La Rosa M., Passalacqua G. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010, 105:376-381.